Inovio Pharmaceuticals
INO
#9427
Rank
HK$0.76 B
Marketcap
HK$9.32
Share price
2.59%
Change (1 day)
-30.98%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -HK$22.45

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$22.55. In 2024 the company made an earnings per share (EPS) of -HK$30.93 an increase over its 2023 EPS that were of -HK$47.69.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$22.45-27.43%
2024-HK$30.93-35.14%
2023-HK$47.69-56.62%
2022-HK$109.94-19.54%
2021-HK$136.6535.9%
2020-HK$100.55-11.57%
2019-HK$113.7015.24%
2018-HK$98.67-2.78%
2017-HK$101.496.93%
2016-HK$94.91134.88%
2015-HK$40.41-29.51%
2014-HK$57.32-57.34%
2013-HK$134.37146.55%
2012-HK$54.5020.83%
2011-HK$45.10-29.41%
2010-HK$63.90-48.48%
2009-HK$124.0410%
2008-HK$112.7611.11%
2007-HK$101.49-41.3%
2006-HK$172.90-66.91%
2005-HK$522.46110.61%
2004-HK$248.08-61.63%
2003-HK$646.50186.67%
2002-HK$225.52
2001N/A-100%
2000-HK$180.42-63.64%
1999-HK$496.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.22-486.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$56.38-350.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.65-147.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$53.64-337.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.24-353.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$29.51-230.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
HK$2.74-112.15%๐Ÿ‡บ๐Ÿ‡ธ USA